Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria Aragón (IIS Aragón), CIBERCV, Zaragoza, Spain.
Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria Aragón (IIS Aragón), CIBERCV, Zaragoza, Spain; Departamento de Fisiatría y Enfermería, Facultad de Ciencias de la Salud y del Deporte, Universidad de Zaragoza, Huesca, Spain.
Atherosclerosis. 2020 Dec;315:24-32. doi: 10.1016/j.atherosclerosis.2020.10.897. Epub 2020 Nov 2.
Glycerol kinase deficiency (GKD) is a rare genetic disorder characterized by hyperglycerolemia and glyceroluria, which could be misdiagnosed as a moderate to severe hypertriglyceridemia (HTG). We aimed to describe four novel cases of GKD, to complete a systematic review of all cases of isolated GKD published so far, and to develop a suspicion clinical diagnostic score for GKD.
We reported four cases with suspicion of GKD and compared their phenotype with 584 males with triglycerides (TG) > 300 mg/dL, selected as control group (HTG non-GKD). The GK gene was sequenced in all cases. Lipoprotein particle concentrations were measured in all cases with GKD. The systematic review involved a PubMed, Cochrane and Scopus databases search to identify anthropometric and biochemical characteristics of all described cases with GKD.
The systematic review retrieved a total of 15 articles involving 39 subjects with GKD. GKD cases reported a history of high TG levels resistant to lipid-lowering therapy. Compared to GKD subjects (n = 43), HTG non-GKD subjects (n = 584) showed significantly higher BMI, total cholesterol, non-HDL cholesterol and gamma-glutamyltransferase, significantly lower HDL cholesterol and TG, and higher prevalence of diabetes. The proposed diagnostic score was significantly higher in GKD than in HTG non-GKD subjects.
This is the first systematic review that compiles all GKD cases reported to date including 4 novel cases, and examine the differential GKD phenotype compared to other types of HTG. The proposed score would have a broad utility in clinical practice to avoid unwarranted lipid lowering treatment in GKD patients.
甘油激酶缺乏症(GKD)是一种罕见的遗传性疾病,其特征为高甘油血症和甘油尿症,可能被误诊为中重度高甘油三酯血症(HTG)。本研究旨在描述 4 例 GKD 新病例,对迄今为止所有孤立性 GKD 病例进行系统回顾,并制定 GKD 的可疑临床诊断评分。
我们报告了 4 例疑似 GKD 的病例,并将其表型与 584 例甘油三酯(TG)>300mg/dL 的男性(作为对照组 HTG 非-GKD)进行比较。所有病例均进行了 GK 基因测序。所有 GKD 患者均检测脂蛋白颗粒浓度。本系统回顾检索了 PubMed、Cochrane 和 Scopus 数据库,以确定所有描述的 GKD 病例的人体测量和生化特征。
系统回顾共检索到 15 篇文章,涉及 39 例 GKD 患者。GKD 患者报告有高 TG 水平病史,对降脂治疗有抵抗。与 GKD 患者(n=43)相比,HTG 非-GKD 患者(n=584)的 BMI、总胆固醇、非 HDL 胆固醇和γ-谷氨酰转移酶显著升高,HDL 胆固醇和 TG 显著降低,糖尿病患病率更高。所提出的诊断评分在 GKD 患者中明显高于 HTG 非-GKD 患者。
这是第一个系统回顾,汇总了迄今为止报告的所有 GKD 病例,包括 4 例新病例,并比较了 GKD 与其他类型 HTG 的不同表型。该评分在临床实践中有广泛的应用价值,可以避免不必要的 GKD 患者降脂治疗。